NDA Regulatory Service supports life science companies all over the world with the single aim to streamline the global development and commercialization process to accelerate patient access to important medical therapies. NDA comprises over 150 dedicated consultants with industry and regulatory agency backgrounds, supported by a network of over 1000 scientific, clinical, regulatory and drug development experts. Their advice covers all phases of development and all major therapeutic areas. NDA supported over 40% of the new medicinal products that were approved in the EU during 2013-2017.
- Bli medlem
- Om SwedenBIO